MMEASE
MMEASE integrates metabolomics datasets from heterogeneous analytical blocks, provides enriched annotation for over 330,000 metabolites, and conducts category- and sub-category-level enrichment analyses to support meta-analysis across diverse experimental setups.
Key Features:
- Integration of Analytical Experiments: Integrates data from multiple analytical blocks to combine datasets originating from different experimental setups for comparative and meta-analysis.
- Enhanced Metabolite Annotation: Provides enriched annotation for over 330,000 metabolites to expand identification and characterization across studies.
- Enrichment Analysis Across Categories: Performs enrichment analysis using multiple categories and sub-categories to identify biological pathways and processes associated with metabolomic signals.
Scientific Applications:
- Large-scale and longitudinal metabolomics studies: Supports integration and comparative analysis of heterogeneous datasets in large-scale and long-term studies.
- Meta-analysis of metabolomics data: Facilitates meta-analyses that combine data from multiple sources to increase statistical power and reliability.
- Biomarker identification and marker selection: Aids identification of metabolic markers through enriched annotation and advanced marker selection strategies.
- Pathway and network interpretation: Enables comprehensive enrichment analyses to elucidate biological pathways and network-level roles in health and disease.
Methodology:
Computational steps explicitly include dataset integration across analytical experiments, enriched annotation of over 330,000 metabolites, and enrichment analysis across categories and sub-categories.
Topics
Details
- Tool Type:
- web application
- Added:
- 1/18/2021
- Last Updated:
- 2/26/2021
Operations
Publications
Yang Q, Li B, Chen S, Tang J, Li Y, Li Y, Zhang S, Shi C, Zhang Y, Mou M, Xue W, Zhu F. MMEASE: Online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis. Journal of Proteomics. 2021;232:104023. doi:10.1016/j.jprot.2020.104023. PMID:33130111.